Safen Ven Greft Lezyonlarda Perkütan Koroner Girişim

Goldman S, Zadina K, Moritz T, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. Journal of the American College of Cardiology 2004, 44(11):2149-2156.

Cameron AA, Davis KB, Rogers WJ. Recurrence of angina after coronary artery bypass surgery: predictors and prognosis (CASS Registry). Journal of the American College of Cardiology 1995, 26(4):895-899.

Roubos N, Rosenfeldt FL, Richards SM, et al. Improved preservation of saphenous vein grafts by the use of glyceryl trinitrate–verapamil solution during harvesting. Circulation 1995, 92(9):31-36.

Roh J-H, Kim Y-H, Yang DH, et al. Fate of Grafts Bypassing Nonischemic Versus Ischemic Inducing Coronary Stenosis. The American journal of cardiology 2018, 122(7):1148-1154.

Zhao Q, Zhu Y, Xu Z, et al. Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year after coronary artery bypass grafting: a randomized clinical trial. Jama 2018, 319(16):1677-1686.

Sun JC, Teoh KH, Lamy A, et al. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study. American heart journal 2010, 160(6):1178-1184.

Gao G, Zheng Z, Pi Y, et al. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery: a single-center, randomized, controlled trial. Journal of the American College of Cardiology 2010, 56(20):1639-1643.

Willemsen LM, Janssen PW, Peper J, et al. Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG) A Randomized, Double-Blind, Placebo-Controlled Trial. Circulation 2020, 142(19):1799-1807.

Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998, 97(9):916-931.

Chen L, Théroux P, Lespérance J, et al. Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery. Journal of the American College of Cardiology 1996, 28(6):1493-1499.

Kang S, Liu Y, Liu X-b. Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials. Clinical therapeutics 2013, 35(8):1125-1136.

Price MJ, Housman L, Teirstein PS. Rescue percutaneous coronary intervention early after coronary artery bypass grafting in the drug-eluting stent era. The American journal of cardiology 2006, 97(6):789-791.

Galassi A, Werner G, Boukhris M, et al. Percutaneous Recanalization of Chronic Total Occlusions: 2019 Consensus. In.: EIJ-D-18-00826; 2014.

Brener SJ, Lytle BW, Casserly IP, et al. Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery. European heart journal 2006, 27(4):413-418.

Neumann F-J, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. European heart journal 2019, 40(2):87-165.

Baim D. Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Randomized trial of a distal embolic protection device during percutaneous intervetion of sapheous vein aoto-corobary bypass grafts. Circulation 2002, 105:1285-1290.

Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003, 108(5):548-553.

Kereiakes DJ, Turco MA, Breall J, et al. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial. JACC: Cardiovascular Interventions 2008, 1(3):248-257.

Dixon SR, Mann JT, Lauer MA, et al. A randomized, controlled trial of saphenous vein graft intervention with a filter‐based distal embolic protection device: TRAP trial. Journal of interventional cardiology 2005, 18(4):233-241.

Holmes DR, Coolong A, O'Shaughnessy C, et al. Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised trial. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2006, 2(2):161-168.

Mauri L, Cox D, Hermiller J, et al. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. Journal of the American College of Cardiology 2007, 50(15):1442-1449.

Brennan JM, Al-Hejily W, Dai D, et al. Three-year outcomes associated with embolic protection in saphenous vein graft intervention: results in 49 325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry. Circulation: Cardiovascular Interventions 2015, 8(3):e001403.

Paul TK, Bhatheja S, Panchal HB, et al. Outcomes of saphenous vein graft intervention with and without embolic protection device: a comprehensive review and meta-analysis. Circulation: Cardiovascular Interventions 2017, 10(12):e005538.

Blackman DJ, Choudhury RP, Banning AP, et al. Failure of the Symbiot™ PTFE-Covered Stent to Reduce Distal Embolization during Percutaneous Coronary Intervention in Saphenous Vein Grafts. JOURNAL OF INVASIVE CARDIOLOGY 2005, 17(11):609.

Gercken U, Lansky AJ, Buellesfeld L, et al. Results of the Jostent coronary stent graft implantation in various clinical settings: Procedural and follow‐up results. Catheterization and cardiovascular interventions 2002, 56(3):353-360.

Mehilli J, Pache J, Abdel-Wahab M, et al. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial. The Lancet 2011, 378(9796):1071-1078.

Colleran R, Kufner S, Mehilli J, et al. Efficacy over time with drug-eluting stents in saphenous vein graft lesions. Journal of the American College of Cardiology 2018, 71(18):1973-1982.

Shah R, Jovin IS, Latham SB, et al. A comprehensive meta‐analysis of randomized controlled trials comparing drug‐eluting stents with bare‐metal stents in saphenous vein graft interventions. Catheterization and Cardiovascular Interventions 2018, 92(7):1229-1236.

Leborgne L, Cheneau E, Pichard A, et al. Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft. American heart journal 2003, 146(3):501-506.

Hong YJ, Pichard AD, Mintz GS, et al. Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions. The American journal of cardiology 2010, 105(2):179-185.

Hong MK, Mehran R, Dangas G, et al. Comparison of time course of target lesion revascularization following successful saphenous vein graft angioplasty versus successful native coronary angioplasty. American Journal of Cardiology 2000, 85(2):256-258.

Pijls NH, Van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. Journal of the American College of Cardiology 2007, 49(21):2105-2111.

Almomani A, Pothineni NV, Edupuganti M, et al. Outcomes of fractional flow reserve-based deferral in saphenous vein graft narrowing. The American journal of cardiology 2018, 122(5):723-728.

Roffi M, Mukherjee D, Chew DP, et al. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation 2002, 106(24):3063-3067.

Members WC, Levine GN, Bates ER, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011, 124(23):e574-e651.

Kapoor N, Yalamanchili V, Siddiqui T, et al. Cardioprotective effect of high‐dose intragraft adenosine infusion on microvascular function and prevention of no‐reflow during saphenous vein grafts intervention. Catheterization and Cardiovascular Interventions 2014, 83(7):1045-1054.